Back
Loncar Cancer Immunotherapy ETF Quote, Financials, Valuation and Earnings
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.
Sell
50
CNCR
Loncar Cancer Immunotherapy ETF
Last Price:
15.44
Seasonality Move:
1.87%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Loncar Cancer Immunotherapy ETF Price Quote
$15.44
Loncar Cancer Immunotherapy ETF Key Stats
Sell
50
Loncar Cancer Immunotherapy ETF (CNCR)
is a Sell
Day range:
$14.94 - $15.83
52-week range:
$9.22 - $17.96
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
82.8K
Avg. volume:
31K
1-year change:
19.27%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does Loncar Cancer Immunotherapy ETF Make?
Data Unavailable
Is Loncar Cancer Immunotherapy ETF Growing As A Company?
Data Unavailable
Loncar Cancer Immunotherapy ETF Stock Price Performance
-
Did Loncar Cancer Immunotherapy ETF Stock Go Up Last Month?
Loncar Cancer Immunotherapy ETF share price went down by -5.22% last month -
Did CNCR's Share Price Rise Over The Last Year?
CNCR share price rose by 19.27% over the past 1 year
What Is Loncar Cancer Immunotherapy ETF 52-Week High & Low?
-
What Is Loncar Cancer Immunotherapy ETF’s 52-Week High Share Price?
Loncar Cancer Immunotherapy ETF has traded as high as $17.96 over the past 52 weeks -
What Is Loncar Cancer Immunotherapy ETF’s 52-Week Low Share Price?
Loncar Cancer Immunotherapy ETF has traded as low as $9.22 over the past 52 weeks
Loncar Cancer Immunotherapy ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Loncar Cancer Immunotherapy ETF?
Data Unavailable
Is Loncar Cancer Immunotherapy ETF Cash Flow Positive?
Data Unavailable
Loncar Cancer Immunotherapy ETF Return On Invested Capital
Data Unavailable
Loncar Cancer Immunotherapy ETF Earnings Date & Stock Price
-
What Is Loncar Cancer Immunotherapy ETF's Stock Price Today?
A single share of CNCR can be purchased today for 15.44 -
What Is Loncar Cancer Immunotherapy ETF’s Stock Symbol?
Loncar Cancer Immunotherapy ETF trades on the nasdaq under the ticker symbol: CNCR -
When Is Loncar Cancer Immunotherapy ETF’s Next Earnings Date?
The next quarterly earnings date for Loncar Cancer Immunotherapy ETF is scheduled on May 2, 2024 -
When Is CNCR's next ex-dividend date?
Loncar Cancer Immunotherapy ETF's next ex-dividend date is December 29, 2021 -
How To Buy Loncar Cancer Immunotherapy ETF Stock?
You can buy Loncar Cancer Immunotherapy ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Loncar Cancer Immunotherapy ETF Competitors
-
Who Are Loncar Cancer Immunotherapy ETF's Competitors?
Below is a list of companies who compete with Loncar Cancer Immunotherapy ETF or are related in some way:
Loncar Cancer Immunotherapy ETF Dividend Yield
Data Unavailable
Loncar Cancer Immunotherapy ETF Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable